Factors predicting erythropoietin resistance among maintenance hemodialysis patients

Salman Mallick, Anca Rafiroiu, Radhika Kanthety, Saima Iqbal, Rabia Malik, Mahboob Rahman

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Background: Erythropoiesis-stimulating agent (ESA) resistance remains incompletely understood among hemodialysis (HD) patients. Method: A retrospective, multicenter study was designed to analyze data from 1,934 patients followed for up to two years. The outcome measure was the erythropoietin resistance index (ERI), defined as erythropoietin dosage over a week divided by the post-HD weight and hemoglobin value. Results: Multivariate analysis revealed albumin, Kt/V, transferrin saturation, statin use and male gender to be inversely related to ERI, whereas parathyroid hormone and angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) use were associated with higher ESA resistance. ERI was statistically lower in patients with higher levels of albumin (p < 0.001) and with higher transferrin saturation levels (p < 0.05). Discussion: The results allow for a better understanding of predictors of erythropoietin resistance among HD patients including not extensively studied factors such as statin and ACEI/ARB use.

Original languageEnglish (US)
Pages (from-to)238-244
Number of pages7
JournalBlood Purification
Issue number4
StatePublished - Jun 1 2012


  • Angiotensin-converting enzyme inhibitors
  • Erythropoietin resistance
  • Hemodialysis

Fingerprint Dive into the research topics of 'Factors predicting erythropoietin resistance among maintenance hemodialysis patients'. Together they form a unique fingerprint.

Cite this